Grant

SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

Open

This NIH pilot program provides grant funding to US small businesses to transition late-stage NIH-funded SBIR or STTR projects toward commercialization. It supports later-stage R&D, clinical studies, manufacturing scale-up, and regulatory assistance.

See your fit

Key facts

Organiser
National Institutes of Health
Deadline
April 5, 2029
Opens
May 28, 2026
Amount
Grant
Open to
United States
Stages
Seed, Series A, Series B and later
Sectors
Biotech, Healthtech

3 details are locked

See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.

See your fit

Key questions about SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

Who can apply to SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)?

SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) is aimed at startups at these stages: Seed, Series A, and Series B and later. Eligible locations: United States. The company must be incorporated in United States. Only startups in these sectors qualify: Biotech and Healthtech.

When is the SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) deadline?

The SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) deadline is April 5, 2029. Applications opened on May 28, 2026.

See more grants in United States

Other programs in this category

Verified on September 28, 2026 against the official page.